Email

Subj: SARS-CoV-2 ORIGINS INVESTIGATION WITH US GOVERNMENT PROGRAM UNDISCLOSED DOCUMENT ANALYSIS Ref:(1) Executive Slide HR00118Soo17 EcoHealth Alliance DEFUSE (2) HR00118S0017-PREEMPT-FP-019-PM Summary (Selectable - Not Recommended) (3) PREEMPT Volume 1 no ESS HR00118S0017 EcoHealth Alliance DEFUSE (4) PREEMPT Volume 2 EHA Final HR00118S0017 EcoHealth Alliance DEFUSE (5) SF424_2_0-V2.0 HR00118S0017 EcoHealth Alliance DEFUSE (6) WIV Budget packet HR001118S0017 EcoHealth Alliance DEFUSE (7) WS00094394-RR_KeyPersonExpanded_2_0-V2.0 HR001118S0017 EcoHealth Alliance DEFUSE (8) WS00094394-RR_PersonalData_1_2-V1.2 HR001118S0017 EcoHealth Alliance DEFUSE 1. SARS-CoV-2 is an American-created recombinant bat vaccine, or its precursor virus. It was created by an EcoHealth Alliance program at the Wuhan Institute of Virology (WIV), as suggested by the reporting surrounding the lab leak hypothesis. The details of this program have been concealed since the pandemic began. These details can be found in the EcoHealth Alliance proposal response to the DARPAi PREEMPTii program Broad Agency Announcement (BAA) HR00118S0017, dated March 2018iii - a document not yet publicly disclosed. The contents of the proposed program are extremely detailed. Peter Daszak lays out step-by-step what the organization intends to do by phase and by location. The primary scientists involved, their roles, and their institutions are indicated. The funding plan for the WIV work is its own document. The reasons why nonpharmaceutical interventions like masks and medical countermeasures like the mRNA vaccines do not work well can be extrapolated from the details. The reasons why the early treatment protocols work as curatives are apparent. SARS-CoV-2's form as it emerged is likely as a precursor, deliberately virulent, humanized recombinant SARSr-CoV that was to be reverse engineered into a live attenuated SARSr-Cov bat vaccine. Its nature can be determined from analysis of its genome with the context provided by the EcoHealth Alliance proposal. Joining this analysis with US intelligence collections on Wuhan will aid this determination. DEFENSE ADVANCED RESEARCH PROJECTS AGENCY 675 NORTH RANDOLPH STREET ARLINGTON, VA 22203-2114 For SHSGAC Use Only - SHSGAC_COVID_119th 011832 UNCLASSIFIED UNCLASSIFIED When synthesized with the EcoHealth Alliance proposal, US collections confirm EcoHealth Alliance was performing the work proposed. The analysts produce their reports in a vacuum, absent the context the proposal provides. As a fellow at DARPA, I could see both, and can do the synthesis. For instance, WIV personnel identified in intelligence reports are named in the proposal, these people use the lexicon of the proposal in the collections, and the virus variants proposed for experimentation are identical to those gleaned by collections. Moreover, I am also privy to information obtained by congressional office investigators and by DRASTICiv, which further corroborates that the program detailed in the BAA response was conducted until it was shut down in April 2020. The purpose of the EcoHealth program, called DEFUSEv in the proposal, was to inoculate bats in the Yunnan, China caves where confirmed SARSCoVs were found. Ostensibly, doing this would prevent another SARS-CoV pandemic; the bats' immune systems would be reinforced to prevent a deadly SARS-CoV from emerging. The specific language used is "inoculate bats with novel chimeric polyvalent spike proteins to enhance their adaptive immune memory against specific high-risk viruses." vi Being defense-related, it makes sense that EcoHealth submitted the proposal first to the Department of Defense, before it settled with NIH/NIAID. The BAA response is dated March 2018 and was submitted by Peter Daszak, president of EcoHealth Alliance. DARPA rejected the proposal because the work was too close to violating the gain-of-function (GoF) moratorium,vii despite what Peter Daszak says in the proposal (that the work would notviii). As is known, Dr. Fauci with NIAID did not reject the proposal. The work took place at the WIV and at several sites in the US, identified in detail in the proposal.ix The EcoHealth Alliance response to the PREEMPT BAA is placed along with other proposal documents in the PREEMPT folder on the DARPA Biological Technologies Office JWICS (top secret) share drive, address: Network/filer/BTO/CI Folder/PREEMPT This folder was empty for a year. The files, completely unmarked with classification or distribution data, were placed in this folder in July 2021, which conspicuously aligns with media reporting, my probing, and Senator Paul's inquiry into NIH/NIAID gain-of-function programs. The unmarked nature combined with the timing signals that the documents were being hidden. No files at DARPA go unmarked in classification or distribution, including proprietary documents. Furthermore, PREEMPT is an unclassified program. The files are also now held by Marine Corps Intelligence Activity (MCIA). They are identified in the reference block above. 2. SARS-CoV-2, hereafter referred to as SARSr-CoV-WIV, is a synthetic spike protein chimera engineered to attach to human ACE2 receptors and For SHSGAC Use Only - SHSGAC_COVID_119th 011833 UNCLASSIFIED UNCLASSIFIED inserted into a recombinant bat SARSr-CoV backbone. It is likely a live vaccine not yet engineered to a more attenuated state that the program sought to create with its final version. It leaked and spread rapidly because it was aerosolized so it could efficiently infect bats in caves, but it was not ready to infect bats yet, which is why it does not appear to infect bats. The reason the disease is so confusing is because it is less a virus than it is engineered spike proteins hitch-hiking a ride on a SARSr-CoV quasispecies swarm. The closer it is to the final live attenuated vaccine form, the more likely that it has been deattentuating since initial escape in August 2019.